Premium
Adult community‐acquired pneumonia caused by macrolide resistant Mycoplasma pneumoniae
Author(s) -
ISOZUMI Rie,
YOSHIMINE Hiroyuki,
MOROZUMI Miyuki,
UBUKATA Kimiko,
ARIYOSHI Koya
Publication year - 2009
Publication title -
respirology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.857
H-Index - 85
eISSN - 1440-1843
pISSN - 1323-7799
DOI - 10.1111/j.1440-1843.2009.01619.x
Subject(s) - clarithromycin , mycoplasma pneumoniae , medicine , community acquired pneumonia , microbiology and biotechnology , macrolide antibiotics , sulbactam , pneumonia , ampicillin , antibiotics , erythromycin , azithromycin , streptococcus pneumoniae , 23s ribosomal rna , virology , antibiotic resistance , biology , ribosome , rna , biochemistry , imipenem , gene
A 28‐year‐old woman with community‐acquired pneumonia was treated with sulbactam/ampicillin and clarithromycin, but failed to show any improvement after 4 days. The antibiotic regimen was changed to pazufloxacin and rapid clinical improvement was seen. Mycoplasma pneumoniae was identified as the causative agent, and adenine (A) to guanine (G) mutation at position 2063 in domain V of the 23S rRNA was noted in the isolate. The minimum inhibitory concentration of macrolide antibiotics, including clarithromycin, of this isolate was greatly elevated.